Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206996 · ClinicalTrials.gov registry record · NA
Exposure Therapy for Auditory Sensitivity in Autism
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03206996: Completed NA study, sponsored by University of Florida.
NCT03206996 is a NA study that has completed, run by University of Florida. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03206996, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families. Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both OCD and ASD. This study is the first to assess the feasibility and efficacy of E/RP for auditory sensory hyper-reactivity in ASD.
Primary Outcome
The Subjective Unit of Distress (SUD) scale is a 0-10 scale used for the child and/or caregiver to report level of distress (i.e., pain, stress, anxiety, discomfort) before, during and/or after exposures to stimuli. We expect that SUDS levels will decrease over time indicating improved ability to tolerate auditory stimuli.
Interventions
- BEHAVIORAL Exposure therapy
- BEHAVIORAL Psycho-education
- BEHAVIORAL Caregiver education/home program development
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-09-30 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03206996 record still lists
NCT03206996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Exposure therapy is the first listed.
NCT03206996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03206996 about?
NCT03206996 is a clinical study titled "Exposure Therapy for Auditory Sensitivity in Autism". Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families. Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both...
What is the current status of trial NCT03206996?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-09-30. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03206996?
The interventions under investigation include: Exposure therapy (BEHAVIORAL), Psycho-education (BEHAVIORAL), Caregiver education/home program development (BEHAVIORAL).
Who is sponsoring clinical trial NCT03206996?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03206996's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI